Health Trials

Infusion Reaction

2

Review clinical trials related to Infusion Reaction. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie

This study is an interventional, explorative, prospective study to show whether shortening of infusion times for patients using nivolumab, pembrolizumab, ipilimumab, trastuzumab, bevacizumab, durvalumab or atezolizumab continues to be associated with an acceptable safety profile. Infusion times will be gradually shortened if tolerability allowes.

Participants needed: 776
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: IsalaUpdated: Mar 30, 2026Locations: 1
Eligibility criteria

Starting treatment with monoclonal antibodies: nivolumab, pembrolizumab ipilimum... [+3]

Other research medication within 4 weeks of the start of the study. [+3]

Read more
Status: Not yet recruiting

A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced NSCLC Receiving Amivantamab-Based Regimens

This study aims to explore the clinical outcomes of Comprehensive Enhanced Preventive Management (CEPM) combined with an amivantamab-containing treatment regimen in Chinese patients with EGFR-mutated advanced NSCLC.

Participants needed: 122
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai Pulmonary Hospital, Shanghai, ChinaUpdated: Mar 13, 2026Locations: 1
Eligibility criteria

Aged at least 18 (or the legal age of consent in the jurisdiction in which the s... [+15]

Pregnancy or breastfeeding. [+2]

Read more